Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for Heavy Drinkers With Bipolar Disorder
NCT01566370Phase 2Terminated
- Sponsor
- Yale University
- Start
- May 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zonisamide in alcohol use disorder (AUD), bipolar disorder (BD), sponsored by Yale University. Started May 2012; status: terminated.
02
Drugs
zonisamide
03
Conditions
alcohol use disorder (AUD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01566370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01566370.